Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support (ARDS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01967602|
Recruitment Status : Unknown
Verified October 2013 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : October 23, 2013
Last Update Posted : October 23, 2013
|Condition or disease|
|ARDS Multi-organ Failure|
|Study Type :||Observational|
|Estimated Enrollment :||70 participants|
|Official Title:||Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support|
|Study Start Date :||October 2011|
|Estimated Primary Completion Date :||April 2015|
|Estimated Study Completion Date :||April 2015|
- Mortality or multi-organ failure [ Time Frame: 7 days ]Patients who survived for more than 7 days after ECMO treatment were defined as survival, and non-survival patients were defined as expired or multiple organ failure incompatible with life within 7 days after ECMO installation.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01967602
|National Taiwan University Hospital||Recruiting|
|Contact: Shuenn-Wen Kuo, MD 0972651448 email@example.com|
|Principal Investigator:||Shuenn-Wen Kuo, MD||National Taiwan University Hospital|